On ECHEMI
Home > Drugs > Sezary syndrome
Sezary syndrome
First reported by Sézary and Bouvrain in 1938, Sézary syndrome is a leukemic, erythrodermic, low-grade malignant T-cell lymphoma. It is characterized by systemic erythroderma, superficial lymphadenopathy, and atypical cells in the peripheral blood. Although patients with typical MF may develop Sézary syndrome, patients with Sézary syndrome usually present with erythroderma from the beginning.
  • Site of disease:

    Skin blood vessels
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Leukocytosis night sweats fatigue secondary infection macules
  • Concurrent disease:

Related Drugs
Prednisolone Acetate Tablets
Indication: It is used for allergic and autoimmune inflammatory diseases and collagen diseases, such as rheumatism, rheumatoid arthritis, lupus erythematosus, severe bronchial asthma, nephrotic syndrome, thrombocytopenic purpura, granulocytopenia, acute lymphoblastic leukemia, various adrenal insufficiency, exfoliative dermatitis, non-herpetic neurodermatitis, eczematoid, etc.
Manufacturer:

Tianjin Jinjin Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.